About Christopher Kemp
Form D filings for SEngine Precision Medicine from 2018 to 2023 list Christopher Kemp as executive officer and promoter.
Christopher Kemp first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Kemp in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Kemp works with at each company, as listed on that company's latest Form D.
SEngine Precision Medicine, Inc. · Form D, Mar 10, 2023
PP
Pablo Prichard
Director
TH
Tony Hsu
Executive officer
EB
Elliott Burkland
Director
CG
Carla Grandori
President and CEO, director